FischlMARichmanDDGriecoMH. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double blind placebo controlled trial. N Engl J Med1987; 317: 185–91
2.
DournonEMatheronSRozenbaumW. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet1988; ii: 1297–302
3.
FischlMARichmanDDCauseyDM. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS related complex. JAMA1989; 262: 2405–10
4.
PinchingAJHelbertMPeddleB. Clinical experience with zidovudine for patients with AIDS and ARC. J Infect1989; 18 (suppl 1): 41–51
5.
FischlMARichmanDDHansenN. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. Ann Intern Med1990; 112: 727–37
6.
YarchoanRMitsuyaHMyersCEBroderS.Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N Engl J Med1989; 321: 726–38
7.
MildvanDRichmanDD. Strategies for the treatment of HIV infection. In: GottliebMS, eds. Current Topics in AIDS, vol 2. Chichester: John Wiley, 1990:235–62
8.
YarchoanRBergGBrouwersP. Response of human immunodeficiency virus associated neurological disease to 3′-azido-2′,3′-dideoxythymidine. Lancet1987; i: 132–5
9.
YarchoanRThomasRVGrafmanJ. Long-term administration of 3′-azido-2′,3′-dideoxythymidine to patients with AIDS related neurological disease. Ann Neurol1988; 23 (suppl): S82–7
10.
PortegiesPde GansJLangeJMA. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ1989; 299: 819–21
11.
RichmanDDFischlMAGriecoMH. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med1987; 317: 192–7
DalakasMCIllaIPezeshkpourGH. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med1990; 322: 1098–105
14.
PanegyresPKPapadimitriouJMHollingsworthPNArmstrongJAKakulasBA. Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment. J Neurol Neurosurg Psychiatry1990; 53: 649–55
15.
PetersBSWinerJLandonDNStotterAPinchingAJ. Mitochondrial myopathy and constitutional symptoms associated with long-term zidovudine therapy in AIDS patients—a prospective clinical and ultrastructural study. AIDS1991; 5 (in press)
16.
FoundationWellcome. Data Sheet: Retrovir (Zidovudine) Capsules. August1990
17.
LarderBADarbyGRichmanDD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science1989; 243: 1731–4
18.
LarderBAKempSD. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science1989; 246: 1155–8
19.
FischlMAParkerCBPettinelliC. A randomised controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. N Engl J Med1990; 323: 1009–14
20.
HelbertMRobinsonDPeddleB. Acute meningoencephalitis on dose-reduction of zidovudine. Lancet1988; i: 1249–52
21.
RichmanDDGrimesJMLagakosSW. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr1990; 3: 743–6
22.
VolberdingPALagakosSWKochMA. Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New Engl J Med1990; 322: 941–9
23.
FriedlandGH. Early treatment for HIV—the time has come. N Engl J Med1990; 322: 1000–2
24.
Anonymous. Zidovudine for symptomless HIV infection. Lancet1990; 335: 821–2
25.
CottonP, Controversy continues as experts ponder zidovudine's role in early HIV infection. JAMA1990; 263: 1605
26.
CarpenterCCJBrookmeyerRSCouchRB. Recommendations for zidovudine: Early infection. State-of-the-art Conference at NIAID. JAMA1990; 263: 1606–7
27.
BirdG.Monitoring of lymphocyte subpopulation changes in the assessment of HIV infection. Genitourin Med1990; 66: 133–7
28.
MillerDPinchingAJ. HIV tests and counselling: Current issues. AIDS1989 (suppl 1):S187–93
